Fatty acid synthase (FASN), the rate-limiting enzyme in the FA synthesis pathway, has been widely reported to promote cancer progression.3 However, studies have shown that cancer cells can also acquire exogenous FAs by upregulating various FA-uptake mechanisms.9–11. Here, FASN is linked to cancer.